(CIA) AstraZeneca has reached an agreement with the European Inclusive Alliance for Vaccines (IVA) to provide up to 400 million doses of COVID-19 for the EU. Deliveries will begin by the end of 2020. AstraZeneca continues to build several supply chains simultaneously around the world, incl. Europe. The company seeks to further expand its production capacity and is open to working with other companies to meet its commitment to promoting access to the vaccine without profit during a pandemic.